NDC 0955-2900-01 - Insulin glargine U-300
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0955-2900
- Requested NDC
- 0955-2900-01
- Package NDCs from labels
- 0955-2900-01, 0955-2900-02
- Manufacturer
- Sanofi-Aventis U.S. LLC | Genzyme Corporation | Sanofi-Aventis Deutschland GmbH
- Effective date
- 2025-05-30
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Insulin glargine U-300 - Sanofi-Aventis U.S. LLC | Genzyme Corporation | Sanofi-Aventis Deutschland GmbH | Sanofi-Aventis U.S. LLC | Genzyme Corporation | Sanofi-Aventis Deutschland GmbH | 2025-05-30 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0955-2900-01 | Insulin glargine U-300 Max | 3 mL in 1 SYRINGE | INJECTION, SOLUTION | 3 | 7 | |
| 0955-2900-02 | Insulin glargine U-300 Max | 2 in 1 CARTON | INJECTION, SOLUTION | 2 | 7 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 0955-2900 | INSULIN GLARGINE U-300 (INSULIN GLARGINE) INJECTION, SOLUTION INSULIN GLARGINE U-300 MAX (INSULIN GLARGINE) INJECTION, SOLUTION [WINTHROP U.S.] | 6 | Current NDC, 2 package rows | 20240913_99ea856d-9562-443a-9422-1006a3cff2f4.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0955-2900-01 | ML - Milliliter | 0955-2900 | d5f1116f-3b0d-4a22-b902-789dc1133f55 | 1 | 2024-02-14 |
| 0955-2900-02 | ML - Milliliter | 0955-2900 | 6dda0158-cc5b-4530-884a-73ea65000a7e | 1 | 2024-02-14 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Equate Redness and Dry Eye Relief | GLYCERIN, NAPHAZOLINE HYDROCHLORIDE | Walmart | 44155cf8-6fd9-d16f-e063-6394a90ac731 | 2025-12-20 | Warnings | PDC6A3C0OX |
| Naughty Kitty Kat | NO GAG DEEP THROAT SPRAY | INKED SUGAR, INC | 170eb644-c72c-5744-e063-6394a90a767d | 2025-12-19 | Warnings | PDC6A3C0OX |
| Artificial Tears | GLYCERIN | Geri-Care Pharmaceuticals, Corp | 7cc437e3-bad9-59be-e053-2991aa0a1da3 | 2025-12-19 | Warnings | PDC6A3C0OX |
| Signature Care Eye Drops Redness and Dry Eye Relief | GLYCERIN, NAPHAZOLINE HYDROCHLORIDE | Better Living Brands LLC | 901f3bbe-e1bb-4e44-879c-711e59813a7f | 2025-12-19 | Warnings | PDC6A3C0OX |
| Sterile Water | WATER | ProPharma Distribution | 386a0a2f-4ff7-f128-e063-6294a90a7d4d | 2025-12-18 | Warnings, Adverse reactions | 059QF0KO0R |
| No-Shift-Lag | ARNICA MONTANA, BELLIS PERENNIS, IPECAC, PHYTOLACCA AMERICANA ROOT, AND ZINC | Miers Laboratories | 704cb13c-3a14-49bc-b636-552d9ceddbdb | 2025-12-18 | Warnings | J41CSQ7QDS |
| Lemon | GLYCERIN | TwinMed LLC | fc88eec0-c66c-5d6d-e053-6294a90a13d2 | 2025-12-18 | Warnings | PDC6A3C0OX |
| SleepEase | AQUILEGIA, AVENA, CHAMOMILLA, COFFEA CRUDA, CYPRIPEDIUM, HUMULUS, KALI PHOS, PASSIFLORA, VALERIANA, ZINC MET | Eight & Company L.L.C | 9bd5fdc8-56b3-4e94-bd2f-1bfa9475c2e6 | 2025-12-18 | Warnings | J41CSQ7QDS |
| Zincum Metallicum 12X | ZINCUM METALLICUM | Natural Creations, Inc | a7fad39f-7e8e-4e12-a1b4-f7904f5718d7 | 2025-12-18 | Warnings | J41CSQ7QDS |
| Category IV | IMMUNE SYSTEM BOOSTER | Vitality Works, Inc. | 790a1b3e-2b5e-426c-9c43-8674c59c9ce1 | 2025-12-17 | Warnings | J41CSQ7QDS |
| NRV-Systemic | NERVOUSE SYSTEM AID | Vitality Works, Inc. | f59d73be-5cb5-4fab-be62-873ea2b515dc | 2025-12-17 | Warnings | J41CSQ7QDS |
| ENC | EMOTIONAL HEALTH BOOSTER | Vitality Works, Inc. | 2f038df1-94be-489b-8f75-10a93dcf83dd | 2025-12-17 | Warnings | J41CSQ7QDS |
| Hemorrhoid | AESCULUS HIPP, HAMAMELIS, ALOE, CALC PHOS, CARBO AN, CARBO VEG, LACHESIS, LYCOPODIUM, MURIATICUM AC, NITRICUM AC, NUX VOM, PAEONIA, RATANHIA, SEPIA, SULPHUR | Natural Creations, Inc | db1b3aef-ba92-417c-b6f6-58e950ed4214 | 2025-12-16 | Warnings | QTT17582CB |
| Artificial Tears | GLYCERIN | NuCare Pharmaceuticals,Inc. | 97a3d8e2-b2c0-3f5d-e053-2a95a90ac49d | 2025-12-15 | Warnings | PDC6A3C0OX |
| ElixirLidoFast Rapid Relief | GLYCERIN, LIDOCAINE, PETROLATUM, AND PHENYLEPHRINE HYDROCHLORIDE | ELIXIR HEALTHCARE USA, LLC. | 45de9dfa-6c89-1eae-e063-6294a90a4dac | 2025-12-13 | Warnings | PDC6A3C0OX |
| Kroger Hemorrhoid | GLYCERIN, LIDOCAINE, PETROLATUM, PHENYLEPHRINE HCL | Kroger Company | 45b2dd86-7fb0-07bf-e063-6394a90a1884 | 2025-12-11 | Warnings | PDC6A3C0OX |
| Firstep Firstflush | EYEWASH | Encon Safety Products, Inc. | a44beb26-79ae-98bd-e053-2995a90a9b74 | 2025-12-09 | Warnings | 059QF0KO0R |
| BUDDATE INONOTUS OBLIQUUS WATER BRILLIANCE MASK | BUTYLENE GLYCOL, GLYCERIN, INONOTUS OBLIQUUS (MUSHROOM) EXTRACT | BUDDATE Co Ltd | 464988ad-557e-13f5-e054-00144ff8d46c | 2025-11-30 | Warnings | PDC6A3C0OX |
| BUDDATE LOTUS MOISTURE ESSENCE | GLYCERIN, NIACINAMIDE, NELUMBO NUCIFERA FLOWER EXTRACT, PORTULACA OLERACEA EXTRACT | BUDDATE Co Ltd | 46499995-8b13-3e5c-e054-00144ff88e88 | 2025-11-30 | Warnings | PDC6A3C0OX |
| JBA ATIV ELECTROLYTE ORS LAVENDER LEMONADE | POTASSIUM,MAGNESIUM,ZINC | Advanced Pharmaceutical Services, Inc. Dba Affordable Quality Pharmaceuticals | 6356c6c3-4c7e-4d4b-aecb-60b92ebf5f1e | 2025-11-28 | Warnings | J41CSQ7QDS |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.